IQVIA to Unveil Third-Quarter 2024 Results
IQVIA Holdings Inc. (NYSE:IQV) has slated the announcement of its financial results for the third quarter of 2024. This eagerly awaited event will transpire before the market opens on a Thursday morning. The leadership team at IQVIA will also lead a conference call and webcast, where they will discuss these results in greater detail.
Details of the Earnings Announcement
The earnings release and associated financial details will be made accessible via the IQVIA Investor Relations website. Interested stakeholders can find the relevant information as it becomes available, ensuring they stay up-to-date with the financial performance of the company.
Participating in the Conference Call
Individuals wishing to participate in this informative conference call need to register beforehand. This process will grant them access to vital information regarding how to join, including dial-in numbers and passcodes. Upon successful registration, attendees will receive a confirmation email packed with the details required for participation in the live call. This is a great opportunity for investors and analysts to engage directly with the IQVIA management team.
Webcast Availability
The company will also provide a replay of the webcast approximately two hours after the live event wraps up. This replay will offer a convenient way for individuals who could not attend the original broadcast to catch up on the discussions and financial insights provided during the call.
About IQVIA Holdings Inc.
IQVIA is recognized globally as a key player in providing clinical research services as well as commercial insights and healthcare intelligence throughout the life sciences and healthcare sectors. The company prides itself on its capacity to leverage IQVIA Connected Intelligence™, offering actionable insights derived from superior health data combined with innovative technologies, advanced analytics, and domain expertise.
A Global Workforce
With a dedicated workforce of around 88,000 employees spanning over 100 countries, IQVIA is on the forefront of healthcare innovation. Their team comprises specialists in healthcare, life sciences, data science, technology, and operational excellence, all united under a common goal—accelerating the development and market introduction of groundbreaking medical treatments aimed at enhancing patient outcomes and public health around the world.
Prioritizing Patient Privacy
IQVIA is also at the vanguard of reinforcing patient privacy. The company employs an array of privacy-enhancing technologies and safeguards that guarantee the protection of individual patient information. Simultaneously, they analyze vast amounts of data to assist healthcare stakeholders in identifying disease trends that could lead to more effective therapeutic paths.
Unlocking Insights for Better Healthcare
Through their insights, IQVIA extends support to biotech firms, medical device manufacturers, pharmaceutical companies, medical researchers, governmental bodies, and payers. Their mission revolves around deepening the understanding of diseases and human behavior to ramp up scientific advancements towards curing various health challenges.
Frequently Asked Questions
When will IQVIA announce its third-quarter 2024 results?
IQVIA is set to announce its results before the market opens on a Thursday in late October.
How can I participate in the earnings call?
To join the earnings call, registration is required in advance. This can be done by using the links provided on the IQVIA Investor Relations website.
Will a replay of the call be available?
Yes, a replay of the conference call will be available approximately two hours after it concludes.
What is IQVIA's main business focus?
IQVIA specializes in delivering clinical research services and healthcare intelligence to the life sciences sector.
How does IQVIA protect patient privacy?
IQVIA utilizes various privacy-enhancing technologies to ensure the protection of individual patient information while generating useful health data insights.
